|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/70 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2450057 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12153605.6 |
| Date of filing the European patent application | 2008-08-14 | |
| (97) | Date of publication of the European application | 2012-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-28 |
| (46) | Date of publication of the claims translation | 2016-12-27 |
| (30) | Number | Date | Country code |
| 955939 P | 2007-08-15 | US |
| (72) |
Walling, John, US
Parent, Stephan D., US
Jonaitis, David T., US
|
| (73) |
Reata Pharmaceuticals Holdings, LLC,
5320 Legacy Drive, Plano, TX 75024,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naujos CDDO metilo esterio formos |
| Novel forms of CDDO methyl ester |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 18 | 347.00 EUR |
| 2026-08-14 |